Boston Scientific Corp (BSX)

23.80
0.50 2.15
NYSE : Health Care
Prev Close 23.30
Open 23.35
Day Low/High 23.24 / 23.91
52 Wk Low/High 15.67 / 24.79
Volume 8.82M
Avg Volume 8.09M
Exchange NYSE
Shares Outstanding 1.36B
Market Cap 31.71B
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Jim Cramer's 'Mad Money' Recap: Here's What's Important Next Week

Jim Cramer's 'Mad Money' Recap: Here's What's Important Next Week

Cramer will be monitoring earnings and the Federal Reserve next week.

Jim Cramer's 'Mad Money' Recap: Strong Demand Keeps Market From Cratering

Jim Cramer's 'Mad Money' Recap: Strong Demand Keeps Market From Cratering

Demand is quite healthy and markets are not going into the abyss, Cramer says.

Cramer: This Is a Market of Stocks, not a Market of Markets

Cramer: This Is a Market of Stocks, not a Market of Markets

Pay attention to what companies are doing to improve themselves, not the hand-wringing from fund managers about Fed intervention.

Jim Cramer's Top Takeaways: Wells Fargo, Boston Scientific

Jim Cramer's Top Takeaways: Wells Fargo, Boston Scientific

Wells Fargo CEO John Stumpf apologizes to the bank's customers and Cramer says Boston Scientific is a stock to buy right now.

Jim Cramer's 'Mad Money' Recap: We're Stuck in Oz With No Way Out

Jim Cramer's 'Mad Money' Recap: We're Stuck in Oz With No Way Out

But Cramer continues to raise cash for his charitable trust so he can pounce on quality stocks as the market takes them lower.

Why Boston Scientific Keeps Rising

Why Boston Scientific Keeps Rising

In the last year, shares of Boston Scientific are up almost 50%. Boston Scientific is putting the problems of the past behind it and has a bright future.

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.

These 5 Rocket Stocks Look Ready for Blastoff

These 5 Rocket Stocks Look Ready for Blastoff

These stocks have both short-term gain catalysts and longer-term growth potential.

Boston Scientific Announces U.S. FDA Approval Of EMBLEM™ MRI S-ICD System

Boston Scientific Announces U.S. FDA Approval Of EMBLEM™ MRI S-ICD System

Approval Grants MR-Conditional Labeling to All EMBLEM S-ICD Systems, Expands ImageReady™ Portfolio

Insider Trading Alert - SXC, BSX And KFS Traded By Insiders

Insider Trading Alert - SXC, BSX And KFS Traded By Insiders

Stocks with insider trader activity include SXC, BSX and KFS

Boston Scientific (BSX) Stock Price Target Raised at Jefferies

Boston Scientific (BSX) Stock Price Target Raised at Jefferies

Jefferies upped its price target to $24 on Boston Scientific (BSX) stock this morning.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BCC, CYS, DISH, ESRT, FCFS, FSI, GIMO, INVA, KSU, NATI, ORC, RMCF, TREE, WLDN, WMGI, WRE, ZION Downgrades: ACIW, ACOR, BSX, DLR, FI, HTH, IP, OVBC, SBBX Initiations: GNRT, MB, PUB Read on to get TheStreet Quant Ratings' detailed report:

Boston Scientific (BSX) Stock Rises After Q2 Revenue Beat

Boston Scientific (BSX) Stock Rises After Q2 Revenue Beat

Boston Scientific (BSX) stock is advancing this morning after the company posted better-than-expected fiscal 2016 second quarter revenue before today's opening bell.

Unusual Social Activity Around Boston Scientific (BSX) Today

Unusual Social Activity Around Boston Scientific (BSX) Today

Trade-Ideas LLC identified Boston Scientific (BSX) as an unusual social activity candidate

Trade-Ideas: Boston Scientific (BSX) Is Today's Post-Market Leader Stock

Trade-Ideas: Boston Scientific (BSX) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Boston Scientific (BSX) as a post-market leader candidate

3 Stocks Dragging In The Health Care Sector

3 Stocks Dragging In The Health Care Sector

TheStreet highlights 3 stocks pushing the health care sector lower today.

Boston Scientific Announces Acquisition Of Cosman Medical

Boston Scientific Announces Acquisition Of Cosman Medical

Addition of Leading Radiofrequency Ablation Company Expands Therapeutic Options for Patients with Chronic Pain

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the health services industry lower today.

5 Big Medtech Stocks Investors Love Right Now -- but Should You Buy Them?

5 Big Medtech Stocks Investors Love Right Now -- but Should You Buy Them?

Can medical technology stocks continue their momentum higher in the second half of the year? Investors say yes, but technical analysis says not necessarily.

Cramer: These Stocks Are the Key to the Bull Market

Cramer: These Stocks Are the Key to the Bull Market

Let me give you the unassailable themes.

Jim Cramer's 'Mad Money' Recap: Stock Prices Just Getting Started

Jim Cramer's 'Mad Money' Recap: Stock Prices Just Getting Started

Listen to what the companies are actually telling you. Then assess what that might mean for the future, Cramer says.

IIROC Trade Resumption - BSX

IIROC Trade Resumption - BSX

IIROC Trading Halt - BSX; NWH.UN

IIROC Trading Halt - BSX; NWH.UN

Medtronic Acquires HeartWare With Some Activist Inspiration

Medtronic Acquires HeartWare With Some Activist Inspiration

Engaged Capital agitated against the cardiac medical device maker's buy of an Israeli company and pushed for a new board member that once led the acquirer's M&A efforts.

Jim Cramer -- 'The Real Market's Healthier,' So Ignore the Bears

Jim Cramer -- 'The Real Market's Healthier,' So Ignore the Bears

There is so much buying power in so many new areas.

Stocks Fall Short of Extending Three-Day Winning Streak

Stocks Fall Short of Extending Three-Day Winning Streak

Wall Street made its best effort to extend a three-day winning streak into a fourth session on Thursday but last-minute moves toward the flatline weren't enough.